life insurance-linked securities

Share

Vida Capital acquires longevity life settlement asset manager Avmont

Vida Capital, Inc., the alternative investment manager with a life settlement and insurance-linked securities (ILS) focus, has added to its life and longevity asset management scope, with the acquisition of specialist Avmont, LLC. Vida Capital is of course a joint-venture partner in insurance-linked securities (ILS) and collateralised reinsurance asset manager Merion read the full article →

Artemis Live: Interview with Niklaus Hilti, Credit Suisse Insurance Linked Strategies

Our latest video interview is with Niklaus Hilti, Chief Executive Officer and Chief Investment Officer of Credit Suisse Insurance Linked Strategies, who kindly joined us to discuss the current status of the ILS investment space and reinsurance market trends. All of our Artemis Live video interviews can be accessed directly from read the full article →

Life ILS outlook positive despite Covid-19, says Securis’ Luca Tres

The ongoing Covid-19 pandemic is expected to have a limited impact on the life insurance-linked securities (ILS) sector, and despite the outlook for life insurance markets being downgraded, the future looks positive for life ILS. This is according to Luca Tres, Partner at Securis Investment Partners, who in a recent interview read the full article →

Knipe launches life focused Kilter Finance, KKR commits up to $500m

Kilter Finance has been formally launched today by its founder Dan Knipe, a well-known figure in the life insurance-linked securities and investments marketplace. Knipe was most recently the Deputy Chief Investment Officer at specialist insurance-linked securities (ILS) manager Leadenhall Capital Partners LLP where he managed the life and mortality linked investment read the full article →

Carlisle Management deploys life settlement fund at above target returns

Carlisle Management Company, a Luxembourg headquartered global alternatives investment firm, has announced the successful deployment of its life settlements fund at above target returns. Carlisle Management is focused on the life settlements area of the insurance-linked securities (ILS) market and its funds are backed by institutional clients including pension funds and read the full article →

Leadenhall adds senior Life & Alt Credit originator, restructures team

Leadenhall Capital Partners LLP, the London headquartered insurance linked securities (ILS) and reinsurance related investments manager, has added senior resource to its Life and Alternative Credit team and restructured it. The Life and Alternative Credit insurance-linked investing team at Leadenhall Capital Partners has been reorganised into three distinct units, all of read the full article →

Leadenhall invests in health insurer Friday Health Plans

Leadenhall Capital Partners LLP, the London headquartered specialist insurance linked securities (ILS) and reinsurance related investments manager, has participated in a funding round for a health insurance start-up in Colorado named Friday Health Plans. Friday Health Plans is a Denver, Colorado-based health insurance holding company that largely underwrites individual and read the full article →

Swiss Re finally extricates capital from closed life business, sells ReAssure

Global reinsurance firm Swiss Re has finally achieved its long-held goal of freeing up some of its capital that was locked up in its closed life insurance book consolidator and is set to sell its ReAssure business to Phoenix Group. As far back as 2011, Swiss Re regularly discussed its desire read the full article →

Leadenhall strengthens Life and Alternative Credit investments team

Leadenhall Capital Partners LLP, the London headquartered insurance linked securities (ILS) and reinsurance related investments manager, has strengthened its Life and Alternative Credit team with a new hire and a key investment committee appointment. Leadenhall operates a diversified ILS investment platform, across both non-life and life segments of the insurance and read the full article →

Most ILS allocators expect returns of up to 5%, but 33% expect 10%+

The majority of institutional investors allocating to the insurance-linked securities (ILS) asset class are only expecting returns of up to 5%, confirming that for many, such as pension funds, ILS and reinsurance allocations are not an area where too much risk is being sought to add to portfolios However, a significant read the full article →